Zenas BioPharma (ZBIO) EPS (Basic) (2023 - 2026)
Zenas BioPharma's (ZBIO) quarterly EPS (Basic) came in at -$1.46 in Q1 2026, down 81.28% year-on-year from -$7.78 in Q1 2025, and up 74.07% quarter-over-quarter from -$5.61 in Q4 2025.
Zenas BioPharma (ZBIO) EPS (Basic) (2023 - 2026) Analysis & Trends
Zenas BioPharma's EPS (Basic) history runs 4 years deep, the most recent figure standing at -$1.46 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 81.28% year-over-year to -$1.46 in Q1 2026; TTM through Mar 2026 was -$7.84, a 101.77% decrease from a year earlier, with the FY2025 full-year figure at -$8.68, up 26.99% from the prior year.
- EPS (Basic) grew to -$1.46 in Q1 2026 per ZBIO's latest filing, from -$5.61 in the prior quarter.
- Across five years, EPS (Basic) topped out at $23.16 in Q3 2023 and bottomed at -$24.23 in Q2 2024.
- The 4-year median for EPS (Basic) is -$3.95 (2024), against an average of -$5.43.
- Across the five-year window, EPS (Basic) plunged 121.65% in 2024 and soared 95.51% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$21.46 in 2023, then jumped by 81.58% to -$3.95 in 2024, then plunged by 42.03% to -$5.61 in 2025, then soared by 74.07% to -$1.46 in 2026.
- Per Business Quant, the three latest ZBIO EPS (Basic) figures stand at -$1.46 (Q1 2026), -$5.61 (Q4 2025), and -$1.22 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Zenas BioPharma | 1.72 Bn | 1.72 Bn | - | -1.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 |
| Dec 31, 2025 | -5.61 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -1.25 |
| Mar 31, 2025 | -0.80 |
| Dec 31, 2024 | -3.95 |
| Sep 30, 2024 | -5.02 |
| Jun 30, 2024 | -24.23 |
| Mar 31, 2024 | -17.89 |
| Dec 31, 2023 | -21.46 |
| Sep 30, 2023 | 23.16 |